Free Trial

Geode Capital Management LLC Acquires 13,932 Shares of Exponent, Inc. (NASDAQ:EXPO)

Exponent logo with Business Services background

Geode Capital Management LLC increased its stake in shares of Exponent, Inc. (NASDAQ:EXPO - Free Report) by 0.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,519,584 shares of the business services provider's stock after acquiring an additional 13,932 shares during the quarter. Geode Capital Management LLC owned approximately 2.99% of Exponent worth $135,419,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also bought and sold shares of EXPO. Franklin Resources Inc. increased its stake in shares of Exponent by 5.4% in the fourth quarter. Franklin Resources Inc. now owns 3,710 shares of the business services provider's stock worth $331,000 after buying an additional 189 shares during the period. Axiom Investors LLC DE increased its position in shares of Exponent by 1.6% in the fourth quarter. Axiom Investors LLC DE now owns 118,567 shares of the business services provider's stock valued at $10,564,000 after acquiring an additional 1,810 shares during the period. CIBC Private Wealth Group LLC raised its stake in shares of Exponent by 3.8% during the fourth quarter. CIBC Private Wealth Group LLC now owns 4,418 shares of the business services provider's stock valued at $394,000 after acquiring an additional 161 shares during the last quarter. Arrowstreet Capital Limited Partnership boosted its holdings in shares of Exponent by 1,061.1% during the fourth quarter. Arrowstreet Capital Limited Partnership now owns 85,790 shares of the business services provider's stock worth $7,644,000 after purchasing an additional 78,401 shares during the period. Finally, Brown Brothers Harriman & Co. bought a new stake in shares of Exponent in the fourth quarter worth about $50,000. 92.37% of the stock is owned by hedge funds and other institutional investors.

Exponent Price Performance

EXPO traded up $1.32 during midday trading on Friday, reaching $80.32. 307,072 shares of the company's stock traded hands, compared to its average volume of 242,311. Exponent, Inc. has a 52 week low of $73.83 and a 52 week high of $115.75. The firm has a fifty day moving average of $83.53 and a two-hundred day moving average of $93.26. The stock has a market capitalization of $4.08 billion, a price-to-earnings ratio of 37.89 and a beta of 0.84.

Exponent (NASDAQ:EXPO - Get Free Report) last announced its quarterly earnings results on Thursday, February 6th. The business services provider reported $0.46 EPS for the quarter, topping analysts' consensus estimates of $0.40 by $0.06. Exponent had a return on equity of 27.27% and a net margin of 19.52%. During the same period last year, the business earned $0.41 earnings per share. Sell-side analysts forecast that Exponent, Inc. will post 1.98 EPS for the current year.

Insider Activity

In other Exponent news, VP Richard Reiss sold 1,736 shares of Exponent stock in a transaction that occurred on Wednesday, February 26th. The stock was sold at an average price of $85.93, for a total transaction of $149,174.48. Following the sale, the vice president now directly owns 1,800 shares of the company's stock, valued at approximately $154,674. The trade was a 49.10 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 2.10% of the company's stock.

About Exponent

(Free Report)

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.

Read More

Institutional Ownership by Quarter for Exponent (NASDAQ:EXPO)

Should You Invest $1,000 in Exponent Right Now?

Before you consider Exponent, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.

While Exponent currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Buy the Fear: 3 Down Stocks That Could 10x Your Profits
Congress Bought THESE Stocks as Tariffs Tanked the Market
5 Stocks to BUY Now as Tariff Uncertainty Fades

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines